GERMANTOWN – MGS Mfg. Group announced it has acquired
Hospira’s injection molding facility in Buffalo, N.Y.
The transaction is scheduled to close at the end of June
this year. Financial terms were not disclosed.
The Buffalo plant employs 120 people and runs 40
injection molding machines, ranging from 100 ton to 400
ton, producing parts for Hospira’s pharmaceutical and
device businesses, according to the announcement.
As part of the purchase agreement, no Hospira employees
will lose their jobs.
“This represents a strategic move for both companies,”
says Paul Manley, MGS chief operating officer and chief
financial officer, in a statement. “MGS has made, and
will continue to make, substantial investments in
manufacturing technologies and capabilities to increase
service to our health care industry customers. This
opportunity with Hospira will benefit both of our
MGS Mfg. Group is headquartered in Germantown and is a
leading supplier to the global plastics industry of
tight tolerance injection molded components, injection
molds, specialty multishot equipment and automation
“MGS’s expertise in cost-efficient custom manufacturing
and molding of components and sub–assemblies better
positions Hospira to meet customers' evolving needs for
molded parts,” said Matthew Stober, senior vice
president of operations for Hospira, in a statement.
“MGS meets or exceeds the ISO and FDA guidelines for
single-use disposable plastics manufacturing and will
ensure supply continuity is maintained at all Hospira